PURPOSE: To investigate the ability of Canadian intensive care units (ICUs) and ventilators to handle widespread re-emergence of the swine-origin H1N1 virus in the context of an aggressive strategy of vaccination. METHOD: Data collected during the first wave in Winnipeg, Manitoba, were applied to a variety of second wave pandemic models to determine potential ICU and ventilator demand. RESULTS: For attack rates greater than 20% to 25%, significant shortages in ventilators may be expected across Canada regardless of the duration of the pandemic if vaccination is not considered. The shortfall arises largely due to the extended durations that patients must remain on ventilation. From the Winnipeg study, 50% of patients required ventilation for more than two weeks. For larger attack rates of 35%, ventilator demand may exceed capacity for over five weeks, with a peak shortfall of 700 ventilators. Vaccination can significantly reduce the attack rates, and is expected to reduce ventilator demand to manageable levels CONCLUSION: Canada's health care system must be prepared for the possibility of a significant influx of ICU patients during the second wave of swine-origin H1N1. Efficient vaccination and other disease prevention measures can reduce the attack rate to manageable levels.
PURPOSE: To investigate the ability of Canadian intensive care units (ICUs) and ventilators to handle widespread re-emergence of the swine-origin H1N1 virus in the context of an aggressive strategy of vaccination. METHOD: Data collected during the first wave in Winnipeg, Manitoba, were applied to a variety of second wave pandemic models to determine potential ICU and ventilator demand. RESULTS: For attack rates greater than 20% to 25%, significant shortages in ventilators may be expected across Canada regardless of the duration of the pandemic if vaccination is not considered. The shortfall arises largely due to the extended durations that patients must remain on ventilation. From the Winnipeg study, 50% of patients required ventilation for more than two weeks. For larger attack rates of 35%, ventilator demand may exceed capacity for over five weeks, with a peak shortfall of 700 ventilators. Vaccination can significantly reduce the attack rates, and is expected to reduce ventilator demand to manageable levels CONCLUSION: Canada's health care system must be prepared for the possibility of a significant influx of ICU patients during the second wave of swine-origin H1N1. Efficient vaccination and other disease prevention measures can reduce the attack rate to manageable levels.
Authors: Andrea D Hill; Eddy Fan; Thomas E Stewart; William J Sibbald; Eric Nauenberg; Bernard Lawless; Jocelyn Bennett; Claudio M Martin Journal: Can J Anaesth Date: 2009-02-21 Impact factor: 5.063
Authors: M G Baker; N Wilson; Q S Huang; S Paine; L Lopez; D Bandaranayake; M Tobias; K Mason; G F Mackereth; M Jacobs; C Thornley; S Roberts; C McArthur Journal: Euro Surveill Date: 2009-08-27
Authors: Anand Kumar; Ryan Zarychanski; Ruxandra Pinto; Deborah J Cook; John Marshall; Jacques Lacroix; Tom Stelfox; Sean Bagshaw; Karen Choong; Francois Lamontagne; Alexis F Turgeon; Stephen Lapinsky; Stéphane P Ahern; Orla Smith; Faisal Siddiqui; Philippe Jouvet; Kosar Khwaja; Lauralyn McIntyre; Kusum Menon; Jamie Hutchison; David Hornstein; Ari Joffe; Francois Lauzier; Jeffrey Singh; Tim Karachi; Kim Wiebe; Kendiss Olafson; Clare Ramsey; Sat Sharma; Peter Dodek; Maureen Meade; Richard Hall; Robert A Fowler Journal: JAMA Date: 2009-10-12 Impact factor: 56.272
Authors: Steven A R Webb; Ville Pettilä; Ian Seppelt; Rinaldo Bellomo; Michael Bailey; David J Cooper; Michelle Cretikos; Andrew R Davies; Simon Finfer; Peter W J Harrigan; Graeme K Hart; Belinda Howe; Jonathan R Iredell; Colin McArthur; Imogen Mitchell; Siouxzy Morrison; Alistair D Nichol; David L Paterson; Sandra Peake; Brent Richards; Dianne Stephens; Andrew Turner; Michael Yung Journal: N Engl J Med Date: 2009-10-08 Impact factor: 91.245
Authors: Seema Jain; Laurie Kamimoto; Anna M Bramley; Ann M Schmitz; Stephen R Benoit; Janice Louie; David E Sugerman; Jean K Druckenmiller; Kathleen A Ritger; Rashmi Chugh; Supriya Jasuja; Meredith Deutscher; Sanny Chen; John D Walker; Jeffrey S Duchin; Susan Lett; Susan Soliva; Eden V Wells; David Swerdlow; Timothy M Uyeki; Anthony E Fiore; Sonja J Olsen; Alicia M Fry; Carolyn B Bridges; Lyn Finelli Journal: N Engl J Med Date: 2009-10-08 Impact factor: 91.245
Authors: Joël Mossong; Niel Hens; Mark Jit; Philippe Beutels; Kari Auranen; Rafael Mikolajczyk; Marco Massari; Stefania Salmaso; Gianpaolo Scalia Tomba; Jacco Wallinga; Janneke Heijne; Malgorzata Sadkowska-Todys; Magdalena Rosinska; W John Edmunds Journal: PLoS Med Date: 2008-03-25 Impact factor: 11.069
Authors: Famke Aeffner; Anna Bratasz; Emilio Flaño; Kimerly A Powell; Ian C Davis Journal: Am J Respir Cell Mol Biol Date: 2012-06-07 Impact factor: 6.914
Authors: Seyed M Moghadas; Nick J Pizzi; Jianhong Wu; Susan E Tamblyn; David N Fisman Journal: Influenza Other Respir Viruses Date: 2010-11-03 Impact factor: 4.380
Authors: Hsin-Chan Huang; Ozgur M Araz; David P Morton; Gregory P Johnson; Paul Damien; Bruce Clements; Lauren Ancel Meyers Journal: Emerg Infect Dis Date: 2017-06 Impact factor: 6.883